Contact

All Stories

  1. Towards Automatic Detection of Misinformation in Online Medical Videos

    Article • October 2019, ACM (Association for Computing Machinery)

    Rui HOU, Dr Stacy Loeb

  2. Twitter-based Prostate Cancer Journal Club (#ProstateJC) Promotes Multidisciplinary Global Scientific Discussion and Research Dissemination

    Article • European Urology, May 2019, Elsevier

    Dr Stacy Loeb

  3. Dissemination of Misinformative and Biased Information about Prostate Cancer on YouTube

    Article • European Urology, April 2019, Elsevier

    Dr Stacy Loeb

  4. Twitter response to the 2018 US Preventive Services Task Force guidelines on prostate cancer screening

    Article • BJU International, March 2019, Wiley

    Dr Stacy Loeb

  5. Quantifying downstream impact of inappropriate staging imaging in a cohort of veterans with low- and intermediate-risk incident prostate cancer

    Article • Urologic Oncology Seminars and Original Investigations, February 2019, Elsevier

    Dr Stacy Loeb

  6. Defining Intermediate Risk Prostate Cancer Suitable for Active Surveillance

    Article • The Journal of Urology, February 2019, Wolters Kluwer Health

    Dr Stacy Loeb

  7. Online Professionalism—2018 Update of European Association of Urology (@Uroweb) Recommendations on the Appropriate Use of Social Media

    Article • European Urology, November 2018, Elsevier

    Dr Stacy Loeb

  8. Social media coverage of scientific articles immediately after publication predicts subsequent citations: #SoMe_Impact Score (Preprint)

    Article • September 2018, JMIR Publications Inc.

    Dr Stacy Loeb

  9. Crowdfunding for prostate cancer and breast cancer

    Article • BJU International, June 2018, Wiley

    Dr Stacy Loeb

  10. Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015

    Article • JAMA, June 2018, American Medical Association (AMA)

    Dr Stacy Loeb

  11. A Multi-Institutional Prospective Trial Confirms Noninvasive Blood Test Maintains Predictive Value in African American Men

    Article • The Journal of Urology, June 2018, Elsevier

    Dr Stacy Loeb

  12. Public online reporting from a nationwide population-based clinical prostate cancer register

    Article • BJU International, April 2018, Wiley

    Dr Stacy Loeb

  13. Prostate cancer and social media

    Article • Nature Reviews Urology, April 2018, Springer Science + Business Media

    Dr Stacy Loeb

  14. Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer

    Article • Journal of Clinical Oncology, February 2018, American Society of Clinical Oncology (ASCO)

    Dr Stacy Loeb

  15. Biomarkers in active surveillance

    Article • Translational Andrology and Urology, February 2018, AME Publishing Company

    Dr Stacy Loeb

  16. Informational needs during active surveillance for prostate cancer: A qualitative study

    Article • Patient Education and Counseling, February 2018, Elsevier

    Dr Stacy Loeb

  17. Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions

    Article • European Urology, December 2017, Elsevier

    Dr Stacy Loeb

  18. Educational intervention in prostate cancer

    Article • BJU International, November 2017, Wiley

    Dr Stacy Loeb

  19. Twitter Activity Associated With U.S. News and World Report Reputation Scores for Urology Departments

    Article • Urology, October 2017, Elsevier

    Dr Stacy Loeb

  20. Management of Prostate Cancer in Sweden

    Article • JAMA Oncology, October 2017, American Medical Association (AMA)

    Dr Stacy Loeb

  21. Re: The Prostate Health Index Adds Predictive Value to Multi-parametric MRI in Detecting Significant Prostate Cancers in a Repeat Biopsy Population

    Article • European Urology, October 2017, Elsevier

    Dr Stacy Loeb

  22. Genomic testing for localized prostate cancer

    Article • Current Opinion in Urology, September 2017, Wolters Kluwer Health

    Dr Stacy Loeb

  23. An Update of the American Urological Association White Paper on the Prevention and Treatment of the More Common Complications Related to Prostate Biopsy

    Article • The Journal of Urology, August 2017, Elsevier

    Dr Stacy Loeb

  24. Biomarkers for Prostate Biopsy and Risk Stratification of Patients with Newly Diagnosed Prostate Cancer

    Article • Urology Practice, July 2017, Elsevier

    Dr Stacy Loeb

  25. Shift from protocol-based to personalized medicine in active surveillance: beginning of a new era

    Article • BJU International, June 2017, Wiley

    Dr Stacy Loeb

  26. Tweet this: how advocacy for breast and prostate cancers stacks up on social media

    Article • BJU International, June 2017, Wiley

    Dr Stacy Loeb

  27. Meta-Analysis of the Association Between Phosphodiesterase Inhibitors (PDE5Is) and Risk of Melanoma

    Article • JNCI Journal of the National Cancer Institute, May 2017, Oxford University Press (OUP)

    Dr Stacy Loeb

  28. Newsworthiness vs scientific impact: are the most highly cited urology papers the most widely disseminated in the media?

    Article • BJU International, May 2017, Wiley

    Dr Stacy Loeb

  29. Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer

    Article • Journal of Clinical Oncology, May 2017, American Society of Clinical Oncology (ASCO)

    Dr Stacy Loeb

  30. The role of prostate cancer biomarkers in undiagnosed men

    Article • Current Opinion in Urology, May 2017, Wolters Kluwer Health

    Dr Stacy Loeb

  31. When is a Negative Prostate Biopsy Really Negative? Repeat Biopsies in Detection and Active Surveillance

    Article • The Journal of Urology, April 2017, Wolters Kluwer Health

    Dr Stacy Loeb

  32. Novel use of Twitter to disseminate and evaluate adherence to clinical guidelines by the European Association of Urology

    Article • BJU International, March 2017, Wiley

    Dr Stacy Loeb, Inge Van oort

  33. Editorial Comment

    Article • The Journal of Urology, March 2017, Wolters Kluwer Health

    Dr Stacy Loeb

  34. Risk of Small Bowel Obstruction After Robot-Assisted vs Open Radical Prostatectomy

    Article • Journal of Endourology, December 2016, Mary Ann Liebert Inc

    Dr Stacy Loeb

  35. Perspectives of Prostate Cancer Patients on Gleason Scores and the New Grade Groups: Initial Qualitative Study

    Article • European Urology, December 2016, Elsevier

    Dr Stacy Loeb

  36. Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer

    Article • BJU International, November 2016, Wiley

    Dr Stacy Loeb

  37. Curating a Digital Identity: What Urologists Need to Know About Social Media

    Article • Urology, November 2016, Elsevier

    Dr Stacy Loeb

  38. Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer Treatment

    Article • European Urology, November 2016, Elsevier

    Dr Stacy Loeb

  39. Qualitative study on decision-making by prostate cancer physicians during active surveillance

    Article • BJU International, October 2016, Wiley

    Dr Stacy Loeb

  40. An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care

    Article • Urology, October 2016, Elsevier

    Dr Stacy Loeb

  41. Activity, content, contributors, and influencers of the twitter discussion on urologic oncology

    Article • Urologic Oncology Seminars and Original Investigations, September 2016, Elsevier

    Dr Stacy Loeb

  42. Beyond prostate-specific antigen

    Article • Current Opinion in Urology, September 2016, Wolters Kluwer Health

    Dr Stacy Loeb

  43. Prognostic implications of 2005 Gleason grade modification. Population-based study of biochemical recurrence following radical prostatectomy

    Article • Journal of Surgical Oncology, August 2016, Wiley

    Dr Stacy Loeb

  44. Complications After Systematic, Random, and Image-guided Prostate Biopsy

    Article • European Urology, August 2016, Elsevier

    Dr Stacy Loeb

  45. Evaluation of the 2015 Gleason Grade Groups in a Nationwide Population-based Cohort

    Article • European Urology, June 2016, Elsevier

    Dr Stacy Loeb

  46. Active Surveillance of Prostate Cancer: Use, Outcomes, Imaging, and Diagnostic Tools

    Article • American Society of Clinical Oncology Educational Book, May 2016, American Society of Clinical Oncology (ASCO)

    Dr Stacy Loeb

  47. Immediate versus delayed prostatectomy: Nationwide population-based study*

    Article • Scandinavian Journal of Urology, April 2016, Taylor & Francis

    Dr Stacy Loeb

  48. Re: Editorial Comment on Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma

    Article • The Journal of Urology, April 2016, Elsevier

    Dr Stacy Loeb

  49. Comparison of Gonadotropin-Releasing Hormone Agonists and Orchiectomy

    Article • JAMA Oncology, April 2016, American Medical Association (AMA)

    Dr Stacy Loeb

  50. Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000-2012

    Article • BJU International, March 2016, Wiley

    Dr Stacy Loeb

  51. Small bowel obstruction and abdominal pain after robotic versus open radical prostatectomy

    Article • Scandinavian Journal of Urology, March 2016, Taylor & Francis

    Dr Stacy Loeb

  52. How Active is Active Surveillance? Intensity of Followup during Active Surveillance for Prostate Cancer in the United States

    Article • The Journal of Urology, March 2016, Elsevier

    Dr Stacy Loeb

  53. Qualitative Twitter analysis of participants, tweet strategies, and tweet content at a major urologic conference

    Article • Canadian Urological Association Journal, February 2016, Canadian Urological Association Journal

    Dr Stacy Loeb

  54. Prostate biopsy decisions: one-size-fits-all approach with total PSA is out and a multivariable approach with the Prostate Health Index is in

    Article • BJU International, February 2016, Wiley

    Dr Stacy Loeb

  55. Postoperative mortality 90 days after robot-assisted laparoscopic prostatectomy and retropubic radical prostatectomy: a nationwide population-based study

    Article • BJU International, February 2016, Wiley

    Dr Stacy Loeb

  56. Screening for familial and hereditary prostate cancer

    Article • International Journal of Cancer, February 2016, Wiley

    Dr Stacy Loeb

  57. The Prostate Health Index

    Article • Urologic Clinics of North America, February 2016, Elsevier

    Dr Stacy Loeb

  58. Risk of malignant melanoma in men with prostate cancer: Nationwide, population-based cohort study

    Article • International Journal of Cancer, January 2016, Wiley

    Dr Stacy Loeb

  59. Genomic Predictors of Outcome in Prostate Cancer

    Article • European Urology, December 2015, Elsevier

    Dr Stacy Loeb

  60. Novel survey disseminated through Twitter supports its utility for networking, disseminating research, advocacy, clinical practice and other professional goals

    Article • Canadian Urological Association Journal, October 2015, Canadian Urological Association Journal

    Dr Stacy Loeb

  61. Controversies in management of high-risk prostate and bladder cancer

    Article • BJU International, October 2015, Wiley

    Dr Stacy Loeb

  62. Prostate cancer: Growth of AS in the USA signals reduction in overtreatment

    Article • Nature Reviews Urology, September 2015, Nature

    Dr Stacy Loeb

  63. Editorial Comment

    Article • Urology, September 2015, Elsevier

    Dr Stacy Loeb

  64. Impact of Early Diagnosis of Prostate Cancer on Survival Outcomes

    Article • European Urology Focus, September 2015, Elsevier

    Dr Stacy Loeb

  65. Prostate Cancer on the Web—Expedient Tool for Patients’ Decision-Making?

    Article • Journal of Cancer Education, August 2015, Springer Science + Business Media

    Dr Stacy Loeb

  66. Is Magnetic Resonance Imaging–Transrectal Ultrasound Fusion Biopsy Ready for “Prime Time”?

    Article • European Urology, July 2015, Elsevier

    Dr Stacy Loeb

  67. Future-proofing Gleason Grading: What to Call Gleason 6 Prostate Cancer?

    Article • European Urology, July 2015, Elsevier

    Dr Stacy Loeb

  68. Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer

    Article • European Urology, July 2015, Elsevier

    Dr Stacy Loeb

  69. Population-based study of long-term functional outcomes after prostate cancer treatment

    Article • BJU International, June 2015, Wiley

    Dr Stacy Loeb

  70. Editorial Comment

    Article • Urology, June 2015, Elsevier

    Dr Stacy Loeb

  71. Editorial Comment

    Article • Urology, June 2015, Elsevier

    Dr Stacy Loeb

  72. Active Surveillance for Prostate Cancer: A Systematic Review of Clinicopathologic Variables and Biomarkers for Risk Stratification

    Article • European Urology, April 2015, Elsevier

    Dr Stacy Loeb

  73. Twitter response to the United States Preventive Services Task Force recommendations against screening with prostate‐specific antigen

    Article • BJU International, March 2015, Wiley

    Dr Stacy Loeb

  74. Time to replace prostate-specific antigen (PSA) with the Prostate Health Index (PHI)? Yet more evidence that the PHI consistently outperforms PSA across diverse populations

    Article • BJU International, March 2015, Wiley

    Dr Stacy Loeb

  75. Upper limit of cancer extent on biopsy defining very low-risk prostate cancer

    Article • BJU International, March 2015, Wiley

    Dr Stacy Loeb

  76. Predicting prostate biopsy results—PCA3 versus phi

    Article • Nature Reviews Urology, February 2015, Springer Science + Business Media

    Dr Stacy Loeb

  77. Five-year Nationwide Follow-up Study of Active Surveillance for Prostate Cancer

    Article • European Urology, February 2015, Elsevier

    Dr Stacy Loeb

  78. Social media makes global urology meetings truly global

    Article • BJU International, January 2015, Wiley

    Dr Stacy Loeb

  79. Editorial Comment

    Article • Urology, January 2015, Elsevier

    Dr Stacy Loeb

  80. Editorial Comment

    Article • Urology, January 2015, Elsevier

    Dr Stacy Loeb

  81. Editorial Comment

    Article • Urology, November 2014, Elsevier

    Dr Stacy Loeb

  82. Editorial Comment

    Article • Urology, November 2014, Elsevier

    Dr Stacy Loeb

  83. Editorial Comment

    Article • Urology, November 2014, Elsevier

    Dr Stacy Loeb

  84. Nationwide Population Based Study of Infections after Transrectal Ultrasound Guided Prostate Biopsy

    Article • The Journal of Urology, October 2014, Elsevier

    Dr Stacy Loeb

  85. A rare 8q24 single nucleotide polymorphism (SNP) predisposes North American men to prostate cancer and possibly more aggressive disease

    Article • BJU International, September 2014, Wiley

    Dr Stacy Loeb

  86. Guideline of guidelines: prostate cancer screening

    Article • BJU International, August 2014, Wiley

    Dr Stacy Loeb

  87. Editorial Comment

    Article • Urology, August 2014, Elsevier

    Dr Stacy Loeb

  88. Genetically adjusted prostate‐specific antigen values may prevent delayed biopsies in African‐American men

    Article • BJU International, July 2014, Wiley

    Dr Stacy Loeb

  89. Engaging responsibly with social media: the BJUI guidelines

    Article • BJU International, June 2014, Wiley

    Dr Stacy Loeb, Professor Prokar Dasgupta

  90. Overdiagnosis and Overtreatment of Prostate Cancer

    Article • European Urology, June 2014, Elsevier

    Dr Stacy Loeb

  91. Use of social media in urology: data from the American Urological Association (AUA)

    Article • BJU International, June 2014, Wiley

    Dr Stacy Loeb

  92. Prostate Cancer Risk Alleles are Associated with Prostate Cancer Volume and Prostate Size

    Article • The Journal of Urology, June 2014, Elsevier

    Dr Stacy Loeb

  93. Editorial Commentary

    Article • Urology Practice, May 2014, Elsevier

    Dr Stacy Loeb

  94. Early Detection of Prostate Cancer

    Article • Urologic Clinics of North America, May 2014, Elsevier

    Dr Stacy Loeb

  95. “To Measure Is To Know. If You Cannot Measure It, You Cannot Improve It”: Statistical Modeling Cannot Compensate for Unmeasured Bias

    Article • European Urology, April 2014, Elsevier

    Dr Stacy Loeb

  96. Nationwide, population-based study of prostate cancer stage migration between and within clinical risk categories

    Article • Scandinavian Journal of Urology, March 2014, Taylor & Francis

    Dr Stacy Loeb

  97. Editorial Comment

    Article • Urology, March 2014, Elsevier

    Dr Stacy Loeb

  98. Population Based Study of Predictors of Adverse Pathology among Candidates for Active Surveillance with Gleason 6 Prostate Cancer

    Article • The Journal of Urology, February 2014, Elsevier

    Dr Stacy Loeb

  99. The Melbourne Consensus Statement on the early detection of prostate cancer

    Article • BJU International, January 2014, Wiley

    Dr Stacy Loeb

  100. Editorial Comment

    Article • Urology, January 2014, Elsevier

    Dr Stacy Loeb

  101. The Prostate Health Index: a new test for the detection of prostate cancer

    Article • Therapeutic Advances in Urology, December 2013, SAGE Publications

    Dr Stacy Loeb

  102. The age old question: who benefits from prostate cancer treatment?

    Article • BJU International, December 2013, Wiley

    Dr Stacy Loeb

  103. National Trends in the Utilization of Partial Nephrectomy Before and After the Establishment of AUA Guidelines for the Management of Renal Masses

    Article • Urology, December 2013, Elsevier

    Dr Stacy Loeb

  104. Systematic Review of Complications of Prostate Biopsy

    Article • European Urology, December 2013, Elsevier

    Dr Stacy Loeb

  105. Editorial Comment

    Article • Urology, November 2013, Elsevier

    Dr Stacy Loeb

  106. Population Based Study of Use and Determinants of Active Surveillance and Watchful Waiting for Low and Intermediate Risk Prostate Cancer

    Article • The Journal of Urology, November 2013, Elsevier

    Dr Stacy Loeb

  107. Bacteriuria and antibiotic resistance in catheter urine specimens following radical prostatectomy

    Article • Urologic Oncology Seminars and Original Investigations, October 2013, Elsevier

    Dr Stacy Loeb

  108. Prostate Health Index—improving screening in men with family history

    Article • Nature Reviews Urology, August 2013, Springer Science + Business Media

    Dr Stacy Loeb

  109. Does Delaying Prostate Cancer Treatment Miss the Window of Curability?

    Article • European Urology, August 2013, Elsevier

    Dr Stacy Loeb

  110. Prostate Cancer Imaging Trends After a Nationwide Effort to Discourage Inappropriate Prostate Cancer Imaging

    Article • JNCI Journal of the National Cancer Institute, July 2013, Oxford University Press (OUP)

    Dr Stacy Loeb

  111. Editorial Comment

    Article • Urology, July 2013, Elsevier

    Dr Stacy Loeb

  112. Outcomes of a Bladder Cancer Screening Program Using Home Hematuria Testing and Molecular Markers

    Article • European Urology, July 2013, Elsevier

    Dr Stacy Loeb

  113. Prostate Health Index (PHI): Golden Bullet or Just Another Prostate Cancer Marker?

    Article • European Urology, June 2013, Elsevier

    Dr Stacy Loeb

  114. Personalized Prostate Specific Antigen Testing Using Genetic Variants May Reduce Unnecessary Prostate Biopsies

    Article • The Journal of Urology, May 2013, Elsevier

    Dr Stacy Loeb

  115. Prospective Multicenter Evaluation of the Beckman Coulter Prostate Health Index Using WHO Calibration

    Article • The Journal of Urology, May 2013, Elsevier

    Dr Stacy Loeb

  116. The Utility of Prostate-Specific Antigen Screening and Prostate Cancer Treatment in Elderly Patients

    Article • Current Translational Geriatrics and Experimental Gerontology Reports, April 2013, Springer Science + Business Media

    Dr Stacy Loeb

  117. 2066 FEWER HOSPITAL ADMISSIONS FOR INFECTION AFTER GENTAMICIN AND CEFTRIAXONE PROSTATE BIOPSY PROPHYLAXIS

    Article • The Journal of Urology, April 2013, Elsevier

    Dr Stacy Loeb

  118. 1925 PSA VELOCITY PER PROSTATE VOLUME: A TOOL FOR PROSTATE CANCER DIAGNOSIS

    Article • The Journal of Urology, April 2013, Elsevier

    Dr Stacy Loeb

  119. 661 POPULATION-BASED STUDY OF UTILIZATION AND DETERMINANTS OF ACTIVE SURVEILLANCE AND WATCHFUL WAITING FOR LOW AND INTERMEDIATE RISK PROSTATE CANCER

    Article • The Journal of Urology, April 2013, Elsevier

    Dr Stacy Loeb

  120. 2063 CHARACTERISTICS AND PREDICTORS OF PROSTATE NEEDLE BIOPSY COMPLIANCE

    Article • The Journal of Urology, April 2013, Elsevier

    Dr Stacy Loeb

  121. Genetic Sequence Variants are Associated with Severity of Lower Urinary Tract Symptoms and Prostate Cancer Susceptibility

    Article • The Journal of Urology, March 2013, Elsevier

    Dr Stacy Loeb

  122. Is Repeat Prostate Biopsy Associated with a Greater Risk of Hospitalization? Data from SEER-Medicare

    Article • The Journal of Urology, March 2013, Elsevier

    Dr Stacy Loeb

  123. Does benign prostatic hyperplasia treatment with alpha-blockers affect prostate cancer risk?

    Article • Current Opinion in Urology, January 2013, Wolters Kluwer Health

    Dr Stacy Loeb

  124. Risk of localized and advanced prostate cancer among immigrants versus native-born Swedish men: a nation-wide population-based study

    Article • Cancer Causes & Control, December 2012, Springer Science + Business Media

    Dr Stacy Loeb

  125. The Impact of Anatomical Radical Retropubic Prostatectomy on Cancer Control: The 30-Year Anniversary

    Article • The Journal of Urology, December 2012, Elsevier

    Dr Stacy Loeb

  126. PSA Dynamics

    Article • October 2012, Springer Science + Business Media

    Dr Stacy Loeb

  127. Association of [−2]proPSA with Biopsy Reclassification During Active Surveillance for Prostate Cancer

    Article • The Journal of Urology, October 2012, Elsevier

    Dr Stacy Loeb

  128. Long-term radical prostatectomy outcomes among participants from the European Randomized Study of Screening for Prostate Cancer (ERSPC) Rotterdam

    Article • BJU International, September 2012, Wiley

    Dr Stacy Loeb

  129. External validation of the cancer of the prostate risk assessment (CAPRA) score in a single-surgeon radical prostatectomy series

    Article • Urologic Oncology Seminars and Original Investigations, September 2012, Elsevier

    Dr Stacy Loeb

  130. Novel Technique for Fragment Removal After Percutaneous Management of Large-volume Neobladder Calculi

    Article • Urology, August 2012, Elsevier

    Dr Stacy Loeb

  131. Infectious Complications and Hospital Admissions After Prostate Biopsy in a European Randomized Trial

    Article • European Urology, June 2012, Elsevier

    Dr Stacy Loeb

  132. Prostate-specific antigen screening can be beneficial to younger and at-risk men

    Article • Canadian Medical Association Journal, May 2012, Canadian Medical Association (CMA)

    Dr Stacy Loeb

  133. Use of Baseline Prostate-Specific Antigen Measurements to Personalize Prostate Cancer Screening

    Article • European Urology, May 2012, Elsevier

    Dr Stacy Loeb

  134. 2215 NOMOGRAM WITH “PSA ACCELERATION” PREDICTING HIGH GRADE PROSTATE CANCER

    Article • The Journal of Urology, April 2012, Elsevier

    Dr Stacy Loeb

  135. Prostate cancer: Modeling the outcomes of prostate cancer screening

    Article • Nature Reviews Urology, March 2012, Nature

    Dr Stacy Loeb

  136. Prediction of Prostate Cancer Risk: The Role of Prostate Volume and Digital Rectal Examination in the ERSPC Risk Calculators

    Article • European Urology, March 2012, Elsevier

    Ewout Steyerberg, Dr Stacy Loeb

  137. Editorial Comment

    Article • Urology, March 2012, Elsevier

    Dr Stacy Loeb

  138. Environmental exposures and prostate cancer

    Article • Urologic Oncology Seminars and Original Investigations, March 2012, Elsevier

    Dr Stacy Loeb

  139. AN EXAMINATION OF THE DYNAMIC CHANGES IN PROSTATE-SPECIFIC ANTIGEN OCCURRING IN A POPULATION-BASED COHORT OF MEN OVER TIME

    Article • BJU International, February 2012, Wiley

    Dr Stacy Loeb

  140. Prostate-specific antigen velocity (PSAV) risk count improves the specificity of screening for clinically significant prostate cancer

    Article • BJU International, February 2012, Wiley

    Dr Stacy Loeb

  141. Novel approaches to improve prostate cancer diagnosis and management in early-stage disease

    Article • BJU International, January 2012, Wiley

    Dr Stacy Loeb

  142. Early Detection, Diagnosis, and Staging of Prostate Cancer

    Article • January 2012, Elsevier

    Dr Stacy Loeb

  143. Baseline Prostate-Specific Antigen Testing at a Young Age

    Article • European Urology, January 2012, Elsevier

    Dr Stacy Loeb

  144. Prostate-specific antigen (PSA) should drive doing prostate biopsies

    Article • Urologic Oncology Seminars and Original Investigations, January 2012, Elsevier

    Dr Stacy Loeb

  145. Re: Randomised Prostate Cancer Screening Trial: 20 Year Follow-up

    Article • European Urology, December 2011, Elsevier

    Dr Stacy Loeb

  146. Unusual Presentation of a Mullerian Remnant in an Infant with Recurrent Epididymo-orchitis

    Article • Urology, December 2011, Elsevier

    Dr Stacy Loeb

  147. The relationship between prostate volume and prostate-specific antigen variability: data from the Baltimore Longitudinal Study of Aging and the Johns Hopkins Active Surveillance Program

    Article • BJU International, November 2011, Wiley

    Dr Stacy Loeb

  148. Complications After Prostate Biopsy: Data From SEER-Medicare

    Article • The Journal of Urology, November 2011, Elsevier

    Dr Stacy Loeb

  149. Infection after Transrectal Ultrasonography-Guided Prostate Biopsy: Increased Relative Risks after Recent International Travel or Antibiotic Use

    Article • BJU International, October 2011, Wiley

    Dr Stacy Loeb

  150. Outcomes in patients with Gleason score 8-10 prostate cancer: relation to preoperative PSA level

    Article • BJU International, October 2011, Wiley

    Dr Stacy Loeb

  151. Editorial Comment

    Article • Urology, October 2011, Elsevier

    Dr Stacy Loeb

  152. Prostate Cancer Risk Alleles and Their Associations With Other Malignancies

    Article • Urology, October 2011, Elsevier

    Dr Stacy Loeb

  153. Re: An Empirical Evaluation of Guidelines on Prostate-Specific Antigen Velocity in Prostate Cancer Detection

    Article • JNCI Journal of the National Cancer Institute, September 2011, Oxford University Press (OUP)

    Dr Stacy Loeb

  154. Editorial Comment

    Article • Urology, August 2011, Elsevier

    Dr Stacy Loeb

  155. Editorial Comment

    Article • Urology, August 2011, Elsevier

    Dr Stacy Loeb

  156. Can We Stop Prostate Specific Antigen Testing 10 Years After Radical Prostatectomy?

    Article • The Journal of Urology, August 2011, Elsevier

    Dr Stacy Loeb

  157. GENETIC BASIS FOR PROSTATE CANCER

    Article • July 2011, World Scientific Pub Co Pte Lt

    Dr Stacy Loeb

  158. Use of Empiric Antibiotics in the Setting of an Increased Prostate Specific Antigen

    Article • The Journal of Urology, July 2011, Elsevier

    Dr Stacy Loeb

  159. PREDICTION OF OUTCOMES AFTER RADICAL PROSTATECTOMY IN PATIENTS DIAGNOSED WITH PROSTATE CANCER OF BIOPSY GLEASON SCORE ≥ 8 VIA CONTEMPORARY MULTI(≥12)-CORE PROSTATE BIOPSY

    Article • BJU International, July 2011, Wiley

    Dr Stacy Loeb

  160. Delay of Surgery in Men With Low Risk Prostate Cancer

    Article • The Journal of Urology, June 2011, Elsevier

    Dr Stacy Loeb

  161. A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range

    Article • The Journal of Urology, May 2011, Elsevier

    Dr Stacy Loeb

  162. Should prostate-specific antigen velocity be abandoned?

    Article • Asian Journal of Andrology, April 2011, Medknow

    Dr Stacy Loeb

  163. Germline Sequence Variants and Prostate-Specific Antigen Interpretation

    Article • Clinical Chemistry, March 2011, AACC

    Dr Stacy Loeb

  164. Editorial Comment

    Article • The Journal of Urology, March 2011, Elsevier

    Dr Stacy Loeb

  165. Reply

    Article • Urology, January 2011, Elsevier

    Dr Stacy Loeb

  166. Distribution of PSA Velocity by Total PSA Levels: Data From the Baltimore Longitudinal Study of Aging

    Article • Urology, January 2011, Elsevier

    Dr Stacy Loeb

  167. What Is the True Number Needed to Screen and Treat to Save a Life With Prostate-Specific Antigen Testing?

    Article • Journal of Clinical Oncology, December 2010, American Society of Clinical Oncology (ASCO)

    Dr Stacy Loeb

  168. Significance of preoperative PSA velocity in men with low serum PSA and normal DRE

    Article • World Journal of Urology, December 2010, Springer Science + Business Media

    Dr Stacy Loeb

  169. Number of prostate cancer risk alleles may identify possibly ‘insignificant’ disease

    Article • BJU International, November 2010, Wiley

    Dr Stacy Loeb

  170. Reply

    Article • Urology, November 2010, Elsevier

    Dr Stacy Loeb

  171. Diabetes mellitus and prostate cancer risk

    Article • Expert Review of Endocrinology & Metabolism, November 2010, Taylor & Francis

    Dr Stacy Loeb

  172. Correlation Between Serum Prostate-specific Antigen and Cancer Volume in Prostate Glands of Different Sizes

    Article • Urology, November 2010, Elsevier

    Dr Stacy Loeb

  173. The Vanishing Prostate Cancer Phenomenon

    Article • Urology, September 2010, Elsevier

    Dr Stacy Loeb

  174. What Are the Outcomes of Radical Prostatectomy for High-risk Prostate Cancer?

    Article • Urology, September 2010, Elsevier

    Dr Stacy Loeb

  175. Genetic Prostate Cancer Risk Assessment: Common Variants in 9 Genomic Regions are Associated With Cumulative Risk

    Article • The Journal of Urology, August 2010, Elsevier

    Dr Stacy Loeb

  176. Prostate Specific Antigen at the Initial Diagnosis of Metastasis to Bone in Patients After Radical Prostatectomy

    Article • The Journal of Urology, July 2010, Elsevier

    Dr Stacy Loeb

  177. Interpretation of the prostate-specific antigen history in assessing life-threatening prostate cancer

    Article • BJU International, May 2010, Wiley

    Dr Stacy Loeb

  178. Prostate-Specific Antigen Kinetics During Follow-Up Are an Unreliable Trigger for Intervention in a Prostate Cancer Surveillance Program

    Article • Journal of Clinical Oncology, May 2010, American Society of Clinical Oncology (ASCO)

    Dr Stacy Loeb

  179. Is statin use associated with prostate cancer aggressiveness?

    Article • BJU International, May 2010, Wiley

    Dr Stacy Loeb

  180. Prostate-specific antigen screening: pro

    Article • Current Opinion in Urology, May 2010, Wolters Kluwer Health

    Dr Stacy Loeb

  181. Preoperative Prostate Specific Antigen Doubling Time is Not a Useful Predictor of Biochemical Progression After Radical Prostatectomy

    Article • The Journal of Urology, May 2010, Elsevier

    Dr Stacy Loeb

  182. Utility of the Riskindicator model in screening

    Article • Nature Reviews Urology, April 2010, Springer Science + Business Media

    Dr Stacy Loeb

  183. 1722 USE OF PSA DERIVATIVES TO DETERMINE THE NEED FOR REPEAT BIOPSY

    Article • The Journal of Urology, April 2010, Elsevier

    Dr Stacy Loeb

  184. Regional Variation in Total Cost per Radical Prostatectomy in the Healthcare Cost and Utilization Project Nationwide Inpatient Sample Database

    Article • The Journal of Urology, April 2010, Elsevier

    Dr Stacy Loeb

  185. [-2]Proenzyme Prostate Specific Antigen is More Accurate Than Total and Free Prostate Specific Antigen in Differentiating Prostate Cancer From Benign Disease in a Prospective Prostate Cancer Screening Study

    Article • The Journal of Urology, April 2010, Elsevier

    Dr Stacy Loeb

  186. Benign prostate glands at the bladder neck margin in robotic vs open radical prostatectomy

    Article • BJU International, March 2010, Wiley

    Dr Stacy Loeb

  187. Prostate Biopsy: A Risk-Benefit Analysis

    Article • The Journal of Urology, March 2010, Elsevier

    Dr Stacy Loeb

  188. The Case for Open Radical Prostatectomy

    Article • Urologic Clinics of North America, February 2010, Elsevier

    Dr Stacy Loeb

  189. Treatment Outcomes of Radical Prostatectomy in Potential Candidates for 3 Published Active Surveillance Protocols

    Article • Urology, February 2010, Elsevier

    Dr Stacy Loeb

  190. Accuracy of PCA3 Measurement in Predicting Short-Term Biopsy Progression in an Active Surveillance Program

    Article • The Journal of Urology, February 2010, Elsevier

    Dr Stacy Loeb

  191. Bone mineral content and prostate cancer risk: data from the Baltimore Longitudinal Study of Aging

    Article • BJU International, January 2010, Wiley

    Dr Stacy Loeb

  192. PSA and Beyond: The Past, Present, and Future of Investigative Biomarkers for Prostate Cancer

    Article • The Scientific World JOURNAL, January 2010, Hindawi Publishing Corporation

    Dr Stacy Loeb

  193. Is Prostate-Specific Antigen Surveillance Necessary in Men with Benign Prostate Pathology following Radical Cystoprostatectomy for Bladder Cancer?

    Article • Urologia Internationalis, January 2010, Karger Publishers

    Dr Stacy Loeb

  194. Can Prostate Specific Antigen Velocity Thresholds Decrease Insignificant Prostate Cancer Detection?

    Article • The Journal of Urology, January 2010, Elsevier

    Dr Stacy Loeb

  195. Editorial Comment

    Article • The Journal of Urology, December 2009, Elsevier

    Dr Stacy Loeb

  196. Should Prostate Specific Antigen be Adjusted for Body Mass Index? Data From the Baltimore Longitudinal Study of Aging

    Article • The Journal of Urology, December 2009, Elsevier

    Dr Stacy Loeb

  197. Reducing blood loss in open radical retropubic prostatectomy with prophylactic periprostatic sutures

    Article • BJU International, November 2009, Wiley

    Dr Stacy Loeb

  198. Limitations and use of PSA derivatives in the screening and risk stratification of prostate cancer

    Article • Urologic Oncology Seminars and Original Investigations, November 2009, Elsevier

    Dr Stacy Loeb

  199. Does diabetes mellitus modify the association between 17q12 risk variant and prostate cancer aggressiveness?

    Article • BJU International, November 2009, Wiley

    Dr Stacy Loeb

  200. Tertiary Gleason Patterns and Biochemical Recurrence After Prostatectomy: Proposal for a Modified Gleason Scoring System

    Article • The Journal of Urology, October 2009, Elsevier

    Dr Stacy Loeb

  201. Prostate Volume Changes Over Time: Results From the Baltimore Longitudinal Study of Aging

    Article • The Journal of Urology, October 2009, Elsevier

    Dr Stacy Loeb

  202. Risk Factors, Prevention and Early Detection of Prostate Cancer

    Article • Primary Care Clinics in Office Practice, September 2009, Elsevier

    Dr Stacy Loeb

  203. Does perineural invasion on prostate biopsy predict adverse prostatectomy outcomes?

    Article • BJU International, August 2009, Wiley

    Dr Stacy Loeb

  204. Outcomes of radical prostatectomy for patients with clinical stage T1a and T1b disease

    Article • BJU International, August 2009, Wiley

    Dr Stacy Loeb

  205. Single Nucleotide Polymorphisms and the Likelihood of Prostate Cancer at a Given Prostate Specific Antigen Level

    Article • The Journal of Urology, July 2009, Elsevier

    Dr Stacy Loeb

  206. Is PSA velocity useful?

    Article • Nature Reviews Urology, June 2009, Springer Science + Business Media

    Dr Stacy Loeb

  207. Pathological Outcomes Associated With the 17q Prostate Cancer Risk Variants

    Article • The Journal of Urology, June 2009, Elsevier

    Dr Stacy Loeb

  208. Characteristics of Prostate Cancers Detected at Prostate Specific Antigen Levels Less Than 2.5 ng/ml

    Article • The Journal of Urology, June 2009, Elsevier

    Dr Stacy Loeb

  209. Investigation of Human Anti-mouse Antibodies as Potential Cause of Postprostatectomy PSA Elevation

    Article • Urology, May 2009, Elsevier

    Dr Stacy Loeb

  210. Prostate Specific Antigen Testing Among the Elderly—When To Stop?

    Article • The Journal of Urology, April 2009, Elsevier

    Dr Stacy Loeb

  211. Biomarkers for Prostate Cancer

    Article • Annual Review of Medicine, February 2009, Annual Reviews

    Dr Stacy Loeb

  212. What is the role of digital rectal examination in men undergoing serial screening of serum PSA levels?

    Article • Nature Clinical Practice Urology, January 2009, Nature

    Dr Stacy Loeb

  213. Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA)

    Article • Urologic Oncology Seminars and Original Investigations, January 2009, Elsevier

    Dr Stacy Loeb

  214. A case of gastrointestinal stromal tumor diagnosed on prostate biopsy

    Article • Nature Clinical Practice Urology, December 2008, Nature

    Dr Stacy Loeb

  215. Biochemical recurrence after radical prostatectomy for prevalent versus incident cases of prostate cancer

    Article • Cancer, December 2008, Wiley

    Dr Stacy Loeb

  216. Does PCA3 Help Identify Clinically Significant Prostate Cancer?

    Article • European Urology, November 2008, Elsevier

    Dr Stacy Loeb

  217. Prostate Specific Antigen Assay Standardization Bias Could Affect Clinical Decision Making

    Article • The Journal of Urology, November 2008, Elsevier

    Dr Stacy Loeb

  218. Rebuttal from Authors re: Axel Heidenreich. Identification of High-Risk Prostate Cancer: Role of Prostate-Specific Antigen, PSA Doubling Time and PSA Velocity. Eur Urol 2008;54:976–7

    Article • European Urology, November 2008, Elsevier

    Dr Stacy Loeb

  219. PSA Doubling Time Versus PSA Velocity to Predict High-Risk Prostate Cancer: Data from the Baltimore Longitudinal Study of Aging

    Article • European Urology, November 2008, Elsevier

    Dr Stacy Loeb

  220. Management of Distal Ureter in Laparoscopic Nephroureterectomy—A Comprehensive Review of Techniques

    Article • Urology, November 2008, Elsevier

    Dr Stacy Loeb

  221. PSA Velocity Is Associated With Gleason Score in Radical Prostatectomy Specimen: Marker for Prostate Cancer Aggressiveness

    Article • Urology, November 2008, Elsevier

    Dr Stacy Loeb

  222. Does primary androgen-deprivation therapy improve survival for localized prostate cancer?

    Article • Aging Health, October 2008, Future Medicine

    Dr Stacy Loeb

  223. Does Prostate Growth Confound Prostate Specific Antigen Velocity? Data From the Baltimore Longitudinal Study of Aging

    Article • The Journal of Urology, October 2008, Elsevier

    Dr Stacy Loeb

  224. Complications of Open Radical Retropubic Prostatectomy in Potential Candidates for Active Monitoring

    Article • Urology, October 2008, Elsevier

    Dr Stacy Loeb

  225. The influence of serial prostate-specific antigen (PSA) screening on the PSA velocity at diagnosis

    Article • Cancer, August 2008, Wiley

    Dr Stacy Loeb

  226. Long-Term Rates of Undetectable PSA with Initial Observation and Delayed Salvage Radiotherapy after Radical Prostatectomy

    Article • European Urology, July 2008, Elsevier

    Dr Stacy Loeb

  227. Combined Prostate-specific Antigen Density and Biopsy Features to Predict “Clinically Insignificant” Prostate Cancer

    Article • Urology, July 2008, Elsevier

    Dr Stacy Loeb

  228. Tumor Characteristics of Carriers and Noncarriers of the deCODE 8q24 Prostate Cancer Susceptibility Alleles

    Article • The Journal of Urology, June 2008, Elsevier

    Dr Stacy Loeb

  229. Relationship of Prostate-Specific Antigen Velocity to Histologic Findings in a Prostate Cancer Screening Program

    Article • Urology, June 2008, Elsevier

    Dr Stacy Loeb

  230. Progression after radical prostatectomy for men in their thirties compared to older men

    Article • BJU International, June 2008, Wiley

    Dr Stacy Loeb

  231. Thoracic Complications of Urologic Laparoscopy: Correlation between Radiographic Findings and Clinical Manifestations

    Article • Journal of Endourology, April 2008, Mary Ann Liebert Inc

    Dr Stacy Loeb

  232. Is the utility of prostate-specific antigen velocity for prostate cancer detection affected by age?

    Article • BJU International, April 2008, Wiley

    Dr Stacy Loeb

  233. Comparison of Prostate Specific Antigen Velocity in Screened Versus Referred Patients With Prostate Cancer

    Article • The Journal of Urology, April 2008, Elsevier

    Dr Stacy Loeb

  234. What to Do with an Abnormal PSA Test

    Article • The Oncologist, March 2008, Alphamed Press

    Dr Stacy Loeb

  235. Prostate-Specific Antigen and Prostate Cancer Screening

    Article • January 2008, Springer Science + Business Media

    Dr Stacy Loeb

  236. Characteristics of Prostate Cancer Detected by Digital Rectal Examination Only

    Article • Urology, December 2007, Elsevier

    Dr Stacy Loeb

  237. Prostate Specific Antigen Velocity in Men With Total Prostate Specific Antigen Less Than 4 ng/ml

    Article • The Journal of Urology, December 2007, Elsevier

    Dr Stacy Loeb

  238. Open radical retropubic prostatectomy

    Article • Urologic Oncology Seminars and Original Investigations, November 2007, Elsevier

    Dr Stacy Loeb

  239. Prestenting Improves Ureteroscopic Stone-Free Rates

    Article • Journal of Endourology, November 2007, Mary Ann Liebert Inc

    Dr Stacy Loeb

  240. Improved Stage and Grade-Specific Progression-Free Survival Rates After Radical Prostatectomy in the PSA Era

    Article • Urology, November 2007, Elsevier

    Dr Stacy Loeb

  241. Pathological Features After Radical Prostatectomy in Potential Candidates for Active Monitoring

    Article • The Journal of Urology, September 2007, Elsevier

    Dr Stacy Loeb

  242. Under Diagnosis and Over Diagnosis of Prostate Cancer

    Article • The Journal of Urology, July 2007, Elsevier

    Dr Stacy Loeb

  243. Early versus delayed intervention for prostate cancer: the case for early intervention

    Article • Nature Clinical Practice Urology, June 2007, Nature

    Dr Stacy Loeb

  244. Intermediate-Term Potency, Continence, and Survival Outcomes of Radical Prostatectomy for Clinically High-Risk or Locally Advanced Prostate Cancer

    Article • Urology, June 2007, Elsevier

    Dr Stacy Loeb

  245. Assay Standardization Bias: Different Prostate Cancer Detection Rates and Clinical Outcomes Resulting from Different Assays for Free and Total Prostate-Specific Antigen

    Article • Urology, June 2007, Elsevier

    Dr Stacy Loeb

  246. Risk of Prostate Cancer for Young Men With a Prostate Specific Antigen Less Than Their Age Specific Median

    Article • The Journal of Urology, May 2007, Elsevier

    Dr Stacy Loeb

  247. The role of high-intensity focused ultrasound in prostate cancer

    Article • Current Oncology Reports, April 2007, Springer Science + Business Media

    Dr Stacy Loeb

  248. Prostate-specific antigen in clinical practice

    Article • Cancer Letters, April 2007, Elsevier

    Dr Stacy Loeb

  249. The Association Between Total Prostate Specific Antigen Concentration and Prostate Specific Antigen Velocity

    Article • The Journal of Urology, April 2007, Elsevier

    Dr Stacy Loeb

  250. Prostate Specific Antigen Velocity Threshold for Predicting Prostate Cancer in Young Men

    Article • The Journal of Urology, March 2007, Elsevier

    Dr Stacy Loeb

  251. Use of Prostate-Specific Antigen Velocity to Follow Up Patients with Isolated High-Grade Prostatic Intraepithelial Neoplasia on Prostate Biopsy

    Article • Urology, January 2007, Elsevier

    Dr Stacy Loeb

  252. Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors

    Article • Cancer, January 2007, Wiley

    Dr Stacy Loeb

  253. Does Body Mass Index Affect Preoperative Prostate Specific Antigen Velocity or Pathological Outcomes After Radical Prostatectomy?

    Article • The Journal of Urology, January 2007, Elsevier

    Dr Stacy Loeb

  254. Comparison of Methods for Calculating Prostate Specific Antigen Velocity

    Article • The Journal of Urology, December 2006, Elsevier

    Dr Stacy Loeb

  255. Characteristics of Patients With Familial Versus Sporadic Prostate Cancer

    Article • The Journal of Urology, December 2006, Elsevier

    Dr Stacy Loeb

  256. Survival results in patients with screen-detected prostate cancer versus physician-referred patients treated with radical prostatectomy: Early results

    Article • Urologic Oncology Seminars and Original Investigations, November 2006, Elsevier

    Dr Stacy Loeb

  257. Use of BioGlue in laparoscopic partial nephrectomy

    Article • Urology, August 2006, Elsevier

    Dr Stacy Loeb

  258. What is the prognostic impact of positive surgical margins in surgically treated prostate cancer?

    Article • Nature Clinical Practice Urology, August 2006, Nature

    Dr Stacy Loeb

  259. Lymphovascular invasion in radical prostatectomy specimens: Prediction of adverse pathologic features and biochemical progression

    Article • Urology, July 2006, Elsevier

    Dr Stacy Loeb

  260. Management of the complications of external beam radiotherapy and brachytherapy

    Article • Current Urology Reports, June 2006, Springer Science + Business Media

    Dr Stacy Loeb

  261. Making prostate-specific antigen testing more effective

    Article • Urologic Oncology Seminars and Original Investigations, May 2006, Elsevier

    Dr Stacy Loeb

  262. A Prospective Study of Laparoscopic Radical Nephrectomy for T1 Tumors—Is Transperitoneal, Retroperitoneal or Hand Assisted the Best Approach?

    Article • The Journal of Urology, April 2006, Elsevier

    Dr Stacy Loeb

  263. Management of the complications of external beam radiotherapy and brachytherapy

    Article • Current Prostate Reports, March 2006, Springer Science + Business Media

    Dr Stacy Loeb

  264. Pathological Characteristics of Prostate Cancer Detected Through Prostate Specific Antigen Based Screening

    Article • The Journal of Urology, March 2006, Elsevier

    Dr Stacy Loeb

  265. Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old

    Article • Urology, February 2006, Elsevier

    Dr Stacy Loeb

  266. The PSA Era is not Over for Prostate Cancer

    Article • European Urology, October 2005, Elsevier

    Dr Stacy Loeb